Find Scholarly Works

Search in all content

Filters for Scholarly Works

Search concepts
Selected Filters

Publication Year

  • 2019
  • 2018
  • 2017
  • 2016
  • 2013
  • 2012

Author

  • Keith Lindor

A 42-Year-Old Woman With a New Diagnosis of Sclerosing Cholangitis

Gossard, A. A. & Lindor, K. D., Jun 1 2012, In : Clinical Gastroenterology and Hepatology. 10, 6, p. 593-597 5 p.

Research output: Contribution to journalArticle

3 Scopus citations

Advances in primary sclerosing cholangitis

Horsley-Silva, J. L., Carey, E. J. & Lindor, K., 2016, In : The Lancet Gastroenterology and Hepatology. 1, 1, p. 68-77 10 p.

Research output: Contribution to journalReview article

11 Scopus citations
4 Scopus citations

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis

Hilscher, M., Enders, F. B., Carey, E. J., Lindor, K. & Tabibian, J. H., Mar 1 2016, In : Annals of Hepatology. 15, 2, p. 246-253 8 p.

Research output: Contribution to journalArticle

25 Scopus citations

Antimitochondrial Antibody–Negative Primary Biliary Cholangitis: Is It Really the Same Disease?

Chascsa, D. M. & Lindor, K., Jan 1 2018, (Accepted/In press) In : Clinics in Liver Disease.

Research output: Contribution to journalArticle

3 Scopus citations

An update on cancer risk and surveillance in primary sclerosing cholangitis

Horsley-Silva, J. L., Rodriguez, E. A., Franco, D. L. & Lindor, K., 2017, (Accepted/In press) In : Liver International.

Research output: Contribution to journalArticle

20 Scopus citations

An update on primary sclerosing cholangitis: From pathogenesis to treatment

Imam, M. H., Talwalkar, J. A. & Lindor, K., Mar 1 2013, In : Minerva gastroenterologica e dietologica. 59, 1, p. 49-58 10 p.

Research output: Contribution to journalReview article

5 Scopus citations

A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis

Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., Trauner, M., Jones, D. E., Floreani, A., Hohenester, S., Luketic, V., Shiffman, M., Van Erpecum, K. J., Vargas, V., Vincent, C., Hirschfield, G. M. & 12 others, Shah, H., Hansen, B., Lindor, K., Marschall, H. U., Kowdley, K. V., Hooshmand-Rad, R., Marmon, T., Sheeron, S., Pencek, R., MacConell, L., Pruzanski, M. & Shapiro, D., Aug 18 2016, In : New England Journal of Medicine. 375, 7, p. 631-643 13 p.

Research output: Contribution to journalArticle

358 Scopus citations

A Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety: Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis

Silveira, M. G., Gossard, A. A., Stahler, A. C., Jorgensen, R. A., Petz, J. L., Ali, A. H. & Lindor, K., Mar 1 2017, In : American Journal of Therapeutics. 24, 2, p. e167-e176

Research output: Contribution to journalArticle

16 Scopus citations

Autoimmune hepatitis: A review

Gossard, A. A. & Lindor, K., May 1 2012, In : Journal of Gastroenterology. 47, 5, p. 498-503 6 p.

Research output: Contribution to journalReview article

32 Scopus citations

Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

Tsuda, M., Moritoki, Y., Lian, Z. X., Zhang, W., Yoshida, K., Wakabayashi, K., Yang, G. X., Nakatani, T., Vierling, J., Lindor, K., Gershwin, M. E. & Bowlus, C. L., Feb 1 2012, In : Hepatology. 55, 2, p. 512-521 10 p.

Research output: Contribution to journalArticle

95 Scopus citations

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Chascsa, D. M. & Lindor, K. D., Sep 1 2019, In : Minerva gastroenterologica e dietologica. 65, 3, p. 214-228 15 p.

Research output: Contribution to journalArticle

2 Scopus citations

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

Fung, B. M., Lindor, K. & Tabibian, J. H., 2019, In : World journal of gastroenterology. 25, 6, p. 659-671 13 p.

Research output: Contribution to journalReview article

10 Scopus citations

Challenges of cholangiocarcinoma detection in patients with primary sclerosing cholangitis

Tabibian, J. H. & Lindor, K., 2012, In : Journal of Analytical Oncology. 1, 1, p. 50-55 6 p.

Research output: Contribution to journalArticle

21 Scopus citations

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K., Everson, G. T. & Bowlus, C. L., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Chemoprevention of colorectal cancer with ursodeoxycholic acid: Cons

Carey, E. J. & Lindor, K., Sep 1 2012, In : Clinics and Research in Hepatology and Gastroenterology. 36, SUPPL.1, p. S61-S64

Research output: Contribution to journalArticle

12 Scopus citations

Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis

Quinn, K. P., Tabibian, J. H. & Lindor, K., Dec 1 2016, (Accepted/In press) In : Scandinavian Journal of Gastroenterology. p. 1-5 5 p.

Research output: Contribution to journalArticle

11 Scopus citations

Clinical management of autoimmune biliary diseases

Imam, M. H., Talwalkar, J. A. & Lindor, K., Oct 1 2013, In : Journal of Autoimmunity. 46, p. 88-96 9 p.

Research output: Contribution to journalReview article

13 Scopus citations

Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis

Imam, M. H., Thackeray, E. W. & Lindor, K. D., Feb 1 2013, In : Colorectal Disease. 15, 2, p. 198-203 6 p.

Research output: Contribution to journalArticle

9 Scopus citations

Combination therapy of all-trans retinoic acid with ursodeoxycholic acid in patients with primary sclerosing cholangitis: A human pilot study

Assis, D. N., Abdelghany, O., Cai, S. Y., Gossard, A. A., Eaton, J. E., Keach, J. C., Deng, Y., Setchell, K. D. R., Ciarleglio, M., Lindor, K. & Boyer, J. L., Jan 1 2017, In : Journal of Clinical Gastroenterology. 51, 2, p. e11-e16

Research output: Contribution to journalArticle

16 Scopus citations

Complications, symptoms, quality of life and pregnancy in cholestatic liver disease

Zakharia, K., Tabibian, A., Lindor, K. & Tabibian, J. H., Mar 2018, In : Liver International. 38, 3, p. 399-411 13 p.

Research output: Contribution to journalReview article

15 Scopus citations

Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease

Palmer, M., Regev, A., Lindor, K., Avigan, M. I., Dimick-Santos, L., Treem, W., Marcinak, J. F., Lewis, J. H., Anania, F. A., Seekins, D., Shneider, B. L. & Chalasani, N., Jan 1 2019, (Accepted/In press) In : Alimentary Pharmacology and Therapeutics.

Research output: Contribution to journalReview article

Open Access

Curcumin in hepatobiliary disease: Pharmacotherapeutic properties and emerging potential clinical applications

Hu, R. W., Carey, E. J., Lindor, K. & Tabibian, J. H., Nov 1 2017, In : Annals of Hepatology. 16, 6, p. 835-841 7 p.

Research output: Contribution to journalArticle

17 Scopus citations

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Younossi, Z. M., Loomba, R., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Chalasani, N. P., Anstee, Q. M. & 4 others, Kowdley, K. V., George, J., Goodman, Z. D. & Lindor, K., Jul 2018, In : Hepatology. 68, 1, p. 361-371 11 p.

Research output: Contribution to journalReview article

101 Scopus citations

Current and promising therapy for primary biliary cholangitis

Gossard, A. A. & Lindor, K., Jun 13 2019, In : Expert Opinion on Pharmacotherapy. 20, 9, p. 1161-1167 7 p.

Research output: Contribution to journalReview article

3 Scopus citations

Current pharmacotherapy for cholestatic liver disease

Carey, E. J. & Lindor, K., Dec 1 2012, In : Expert Opinion on Pharmacotherapy. 13, 17, p. 2473-2484 12 p.

Research output: Contribution to journalReview article

29 Scopus citations

Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis

Ponsioen, C. Y., Lindor, K., Mehta, R. & Dimick-Santos, L., Sep 1 2018, In : Hepatology. 68, 3, p. 1174-1188 15 p.

Research output: Contribution to journalReview article

17 Scopus citations

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

Younossi, Z. M., Loomba, R., Anstee, Q. M., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Goodman, Z. D. & 4 others, Chalasani, N. P., Kowdley, K. V., George, J. & Lindor, K., Jul 2018, In : Hepatology. 68, 1, p. 349-360 12 p.

Research output: Contribution to journalReview article

107 Scopus citations

Distinguishing immunoglobulin G4–related disease from its pancreatobiliary mimics: Are we there now?

Tabibian, J. H. & Lindor, K., Aug 1 2016, In : Hepatology. 64, 2, p. 340-343 4 p.

Research output: Contribution to journalEditorial

6 Scopus citations

Editorial: Itching to Know: Role of Fibrates in PBC

Levy, C. & Lindor, K., Jan 1 2018, In : The American journal of gastroenterology. 113, 1, p. 56-57 2 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Tabibian, J. H. & Lindor, K., Apr 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 8, p. 1226-1227 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations
8 Scopus citations

Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study

Eaton, J. E., Nelson, K. M., Gossard, A. A., Carey, E. J., Tabibian, J. H., Lindor, K. D. & LaRusso, N. F., May 4 2019, In : Scandinavian Journal of Gastroenterology. 54, 5, p. 633-639 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Emerging drugs for the treatment of Primary Biliary Cholangitis

Ali, A. H., Tabibian, J. H., Carey, E. J. & Lindor, K., Jan 2 2016, In : Expert Opinion on Emerging Drugs. 21, 1, p. 39-56 18 p.

Research output: Contribution to journalArticle

12 Scopus citations

Emerging therapeutic targets for primary sclerosing cholangitis

Kalani, A., Tabibian, J. H. & Lindor, K., Jul 3 2018, In : Expert Opinion on Orphan Drugs. 6, 7, p. 393-401 9 p.

Research output: Contribution to journalReview article

Emerging treatments for primary sclerosing cholangitis

Rodriguez, E. A., Carey, E. J. & Lindor, K., May 4 2017, In : Expert Review of Gastroenterology and Hepatology. 11, 5, p. 451-459 9 p.

Research output: Contribution to journalReview article

7 Scopus citations

Evaluating sex and gender competencies in the medical curriculum: A case study

Miller, V. M., Flynn, P. M. & Lindor, K. D., Jun 2012, In : Gender Medicine. 9, 3, p. 180-186.e3

Research output: Contribution to journalArticle

12 Scopus citations

Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems

FOLD Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

11 Scopus citations

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
6 Scopus citations

Gall bladder polyps in primary sclerosing cholangitis: Adhere to the guidelines

Gores, G., Lindor, K. D. & Razumilava, N., Jul 1 2012, In : Hepatology. 56, 1, p. 396 1 p.

Research output: Contribution to journalLetter

Heterogeneity of Outcomes Following Liver Transplantation for Primary Sclerosing Cholangitis: Age Matters

Martin, P. & Lindor, K., Sep 30 2017, (Accepted/In press) In : Digestive Diseases and Sciences. p. 1-2 2 p.

Research output: Contribution to journalArticle

2 Scopus citations

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis

Cholankeril, G., Gonzalez, H. C., Satapathy, S. K., Gonzalez, S. A., Hu, M., Khan, M. A., Yoo, E. R., Li, A. A., Kim, D., Nair, S., Wong, R. J., Kwo, P. Y., Harrison, S. A., Younossi, Z. M., Lindor, K. & Ahmed, A., Jun 2018, In : Clinical Gastroenterology and Hepatology. 16, 6, p. 965-973.e2

Research output: Contribution to journalArticle

8 Scopus citations

Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment

Fibrotic Liver Disease Consortium Investigators, Aug 1 2018, In : Clinical Gastroenterology and Hepatology. 16, 8, p. 1342-1350.e1

Research output: Contribution to journalArticle

15 Scopus citations

Inflammatory bowel disease in primary sclerosing cholangitis: A robust yet changing relationship

Sinakos, E., Samuel, S., Enders, F., Loftus, E. V., Sandborn, W. J. & Lindor, K. D., Apr 2013, In : Inflammatory Bowel Diseases. 19, 5, p. 1004-1009 6 p.

Research output: Contribution to journalArticle

28 Scopus citations

Investigational drugs in phase II clinical trials for primary biliary cholangitis

Silveira, M. G. & Lindor, K., Oct 3 2017, In : Expert Opinion on Investigational Drugs. 26, 10, p. 1115-1121 7 p.

Research output: Contribution to journalReview article

3 Scopus citations

Is there Still a Role for Ursodeoxycholic Acid Treatment in Patients with Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis?

Sinakos, E. & Lindor, K. D., Jan 30 2012, Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges: Second Edition. Wiley-Blackwell, p. 156-158 3 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Joint society statement for elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Jan 1 2017, In : Annals of Hepatology. 16, 1, p. 6-7 2 p.

Research output: Contribution to journalEditorial

2 Scopus citations

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Hepatology. 64, 4, p. 1031-1032 2 p.

Research output: Contribution to journalEditorial

4 Scopus citations

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Journal of Hepatology. 65, 4, p. 661-662 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Likelihood of malignancy in gallbladder polyps and outcomes following cholecystectomy in primary sclerosing cholangitis

Eaton, J. E., Thackeray, E. W. & Lindor, K. D., Mar 1 2012, In : American Journal of Gastroenterology. 107, 3, p. 431-439 9 p.

Research output: Contribution to journalArticle

51 Scopus citations